Related Experiment Video
Updated: Oct 3, 2025

12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.7K
Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice
Yanyi Sun1, Cristina Pinto1, Stéphane Camus1
1Université de Paris, PARCC, INSERM, Paris, France.
Journal of the American College of Cardiology
|February 18, 2022
Summary
Marginal zone B (MZB) cells worsen heart repair after myocardial infarction (MI) by increasing inflammation via the microRNA-21 (miR21)/hypoxia-inducible factor-α (HIF-α) pathway. Inhibiting this pathway improves cardiac function post-MI.
Area of Science:
- Cardiovascular Research
- Immunology
- Molecular Biology
Background:
- Mature B lymphocytes influence cardiac recovery following acute myocardial infarction (MI).
- Splenic marginal zone B (MZB) cells are distinct B cell populations with specific functions.
- MicroRNA-21 (miR21) and hypoxia-inducible factor-α (HIF-α) pathways regulate B cell functions.
Purpose of the Study:
- To investigate the specific role of MZB cells in post-ischemic cardiac injury.
- To elucidate the function of endogenous miR21/HIF-α signaling within MZB cells during cardiac repair.
Main Methods:
- Acute myocardial infarction (MI) induced in mice via coronary artery ligation.
- Cardiac function and remodeling assessed using echocardiography and immunohistochemistry.
- MZB cell-specific deletion of Notch signaling or Hif1a to evaluate their roles.
Main Results:
- MI increased miR21-dependent HIF-1α expression, particularly in splenic MZB cells.
- Deficiency or targeted deletion of miR21/HIF-1α in MZB cells improved cardiac function post-MI.
- miR21/HIF-1α signaling in MZB cells promoted CCL7 expression, increasing inflammatory monocyte infiltration and adverse cardiac remodeling.
Conclusions:
- The miR21/HIF-1α pathway in splenic MZB cells plays a critical role in cardiac dysfunction after MI.
- Targeting this pathway in MZB cells offers a potential therapeutic strategy for modulating cardiac function post-MI.

